Binding characteristics reveal partial GABA agonist activities of SR 95531.
Zimmermann
L N
LN
Research Laboratories of Schering AG, West Berlin, FRG.
Schneider
H H
HH
Stephens
D N
DN
D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001921:Brain / Q000378:metabolism; D008140:Lorazepam / Q000031:analogs & derivatives* / Q000378:metabolism; D011724:Pyridazines / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects* / Q000378:metabolism
D014151:Anti-Anxiety Agents; D011724:Pyridazines; D011963:Receptors, GABA-A; D001569:Benzodiazepines; C049853:gabazine; C023842:lormetazepam; D008140:Lorazepam